Investigate the efficacy of Radioderm® Spray in preventing
Study:
Investigate the efficacy of Radioderm® Spray in preventing, delaying or minimizing the incidence of radio-induced cutaneous erythema in women who have undergone irradiation of the breast.
Design:
Total: 100 patients were randomized in 2 groups: Radioderm Spray (53 patients) vs. placebo (47 patients)
Measurements:
Cutaneous toxicity was evaluated. Patients were also given a questionnaire on quality of life and on the cosmetic outcome.
TIME TO APPEARANCE OF G1 CUTANEOUS TOXICITY
Wyniki kliniczne
Appearence of G1 cutaneous erythema in patient treated with Radioderm® Spray occurred at the 18th session on average compared to those treated with placebo (12th session on average).
Radioderm® Spray helped delay the appearence of G1 cutaneous toxicity.
Gatti G. et al.
XXIII National Congress
AIRO
26-29 October 2013
